It's been a banner year for Burning Rock Biotech Limited (BNR), whose shares reached a new 52-week high of $19.50 in yesterday's trading, marking a year-to-date gain of over 180%.
Burning Rock Biotech, founded in 2014 and headquartered in Guangzhou, China, specializes in next-generation sequencing (NGS) and cancer therapy selection (CTS) products for precision oncology.
Subscribe to continue reading the article.
This article is part of our premium content offering.Subscribe with a RTTNews subscription.
Subscribe NowAlready subscribed? Sign in
For comments and feedback: editorial@rttnews.com